| Literature DB >> 34267147 |
Nils Jan Bleeker1, Inge H F Reininga1, Bryan J M van de Wall2, Laurent A M Hendrickx3,4, Frank J P Beeres2, Kaj Ten Duis1, Job N Doornberg1,3, Ruurd L Jaarsma3, Gino M M J Kerkhoffs4, Frank F A IJpma1.
Abstract
OBJECTIVES: To assess the effectiveness of suprapatellar (SP)-nailing versus infrapatellar (IP)-nailing of tibia fractures in anterior knee pain, complications (retropatellar chondropathy, infection, and malalignment) and physical functioning and quality of life. A clinical question-driven and thorough systematic review of current literature is provided. DATA SOURCE: PubMed and Embase databases were searched for studies published between 2010 and 2020 relating to SP and IP-nailing of tibia fractures. The study is performed in concordance with PRISMA-guidelines. STUDY SELECTION: Studies eligible for inclusion were randomized controlled trials, prospective and retrospective observational studies reporting on outcomes of interest. DATA EXTRACTION: Data extraction was performed independently by 2 assessors. Methodological quality and risk of bias was assessed according to the guidelines of the McMaster Critical Appraisal. DATA SYNTHESIS: Continuous variables are presented as means with SD and dichotomous variables as frequency and percentages. The weighted mean, standardized weighted mean differences, and 95% confidence interval were calculated. A pooled analysis could not be performed because of differences in outcome measures, time-points, and heterogeneity.Entities:
Mesh:
Year: 2021 PMID: 34267147 PMCID: PMC8253504 DOI: 10.1097/BOT.0000000000002043
Source DB: PubMed Journal: J Orthop Trauma ISSN: 0890-5339 Impact factor: 2.512
FIGURE 1.Search syntax. Editor's Note: A color image accompanies the online version of this article.
Study Characteristics of Included Studies
| Author | Year | Country | Design | N | Period | Group(s) (n) | OTA/AO-Classification | Outcomes | Follow-up | |
| SP | IP | |||||||||
| Avilucea et al[ | 2016 | USA | RSC | 266 | 2008–2014 | SP (132) vs. IP (134) | 43-A, 43-C1, 43-C2 | Complications | >6 | >6 |
| Cazatto et al[ | 2018 | Italy | RSC | 25 | 2014–2016 | SP (25) | 42-A, 42-B, 42-C | Complications, physical functioning, QoL | 29 (6) | NR |
| Chan et al[ | 2016 | USA | RCT | 25 | 2011–2012 | SP (11) vs. IP (14) | 42-A, 42-B, 42-C | Pain, complications, QoL | 16 (5) | |
| Courtney et al[ | 2015 | USA | RSC | 45 | 2009–2013 | SP (21) vs. IP (24) | 42-A, 42-B, 42-C | Complications, physical functioning | 8 (8) | 13 (10) |
| Cui et al[ | 2019 | China | RSC | 50 | 2014–2016 | SP (24) vs. IP (26) | 42-A, 42-B, 42-C | Pain, physical functioning | 24 (7) | 23 (7) |
| Fu et al[ | 2016 | China | RSC | 23 | 2012–2013 | SP (23) | 41-A2, 41-A3, 42-A, 42-B, 42-C | Complications, physical functioning | 16 (3) | NR |
| Isaac et al[ | 2019 | USA | RSC | 262 | 2011–2016 | SP (91) vs. IP (171) | NR | Pain | 43 (18) | 50 (19) |
| Jones et al[ | 2014 | UK | RSC | 74 | NR | SP (36) vs. IP (38) | 42-A, 42-B, 42-C | Pain, complications, physical functioning, QoL | 23 (6) | 28 (5) |
| Leliveld et al[ | 2012 | NL | RSC | 71 | 1998–2008 | IP (72) | 42-A, 42-B, 42-C | Pain, complications, physical functioning | NR | 84 (37) |
| MacDonald et al[ | 2019 | UK | RCT | 95 | 2011–2013 | SP (53) vs. IP (42) | NR | Pain, complications, physical functioning | >6 | >6 |
| Marecek et al[ | 2018 | USA | RSC | 282 | 2009–2015 | SP (147) vs. IP (142) | NR (open fractures) | Complications | 9 (9) | 11 (13) |
| Mitchell et al[ | 2017 | USA | RSC | 135 | 2011–2016 | SP (139) | NR (open fractures) | Complications | 9 (13) | NR |
| Ozcan et al[ | 2020 | Turkey | RSC | 58 | 2010–2017 | SP (21) vs. IP (37) | NR | Pain, physical functioning | 16 (4) | 33 (19) |
| Sanders et al[ | 2014 | USA | PSC | 36 | 2007–2011 | SP (37) | 42-A, 42-B, 42-C | Pain, complications, physical functioning, QoL | 19 (9) | NR |
Total patients.
Total fractures.
Follow-up in months
RSC, retrospective cohort; PSC, prospective cohort; NR, not reported.
Anterior Knee Pain After SP and IP Approach for Nailing of Tibia Fractures
| Study and Outcome | Groups (n) | 0–12 mo | >12 mo | |||
| SP | IP | SP | IP | |||
| Anterior knee pain | ||||||
| Cases % | ||||||
| Chan et al[ | SP (11) vs. IP (14) | NR | NR | 0 (0%) | 2 (14%) | |
| Jones et al[ | SP (36) vs. IP (38) | NR | NR | 12 (33%) | 16 (42%) | |
| Leliveld et al[ | IP (71) | NR | NR | NR | 27 (38%) | NA |
| Ozcan et al[ | SP (21) vs. IP (37) | NR | NR | 8 (38%) | 17 (46%) | |
| VAS | ||||||
| Chan et al[ | SP (11) vs. IP (14) | NR | NR | Mean 0.4 | Mean 1.5 | NA |
| MacDonald et al[ | SP (53) vs. IP (42) | Mild 36; moderate 1; severe 0 | Mild 22; moderate 1; severe 0 | NR | NR | NA |
| Sanders et al[ | SP (36) | NR | NR | 0 | NR | NA |
| Numeric Rating scale | ||||||
| Isaac et al[ | SP (91) vs. IP (171) | NR | NR | Kneeling 4 (4); resting 2 (3); walking 3 (3) | Kneeling 4 (4); resting 2 (3); walking 3 (3) | NA |
| AWT-K | ||||||
| MacDonald et al[ | SP (53) vs. IP (42) | 36/371 | 18/232 | NR | NR | NA |
| HSS pain score | ||||||
| Cui et al[ | SP (24) vs. IP (26) | NR | NR | 29 (2) | 28 (3) | SMD 0.4 [−0.2 to 0.9] |
| Lysholm pain score | ||||||
| Chan et al[ | SP (11) vs. IP (14) | NR | NR | 24 | 20 | NA |
| Sanders et al[ | SP (36) | NR | NR | 22 | NR | NA |
Visual Analogue scale (0 (no pain)– 10 (worst pain)), Numeric Rating scale (0 (no pain)–10 (worst pain)), AWT-K (Aberdeen weightbearing test)1,2 Proportion of patients who completed the AWT-K as secondary outcome measurer of the test. HSS pain score (0 (complete discomfort)–100 (no discomfort)), Lysholm pain score (0 (heavy pain)–25 (no pain)).
Mild (0–39), moderate (40–79), severe (80–100).
95% CI, 95% confidence interval; NR, not reported, NA, not applicable.
Complications After SP- Versus IP-Nailing for Tibia Fractures
| Complications | Study | Outcome(s) | ||
| SP | IP | |||
| Retropatellar chondropathy cases (%) | ||||
| Chan et al[ | 3 (27%) | 0 (0%) | ||
| Sanders et al[ | 2 (5%) | NR | NA | |
| Infection cases (%) | ||||
| Cazatto et al[ | 0 (0%) | NR | NA | |
| Chan et al[ | 0 (0%) | 0 (0%) | NA | |
| Fu et al[ | 0 (0%) | NR | NA | |
| Leliveld et al[ | NR | Total 4 (6%); deep 1 (1%); superficial 3 (4%) | NA | |
| MacDonald et al[ | 2 (4%) | 0 (0%) | ||
| Marecek et al[ | Total 24 (16%); deep 16 (11%); superficial 8 (5%) | Total 20 (14%); deep 14 (10%); superficial 6 (4%) | ||
| Mitchell et al[ | Total 25 (18%); deep 16 (12%); superficial 9 (7%) | NR | NA | |
| Sanders et al[ | 2 (5%) | NR | NA | |
| Primary angular malalignment cases (%) | ||||
| Avilucea et al[ | 5 (4%) | 35 (26%) | ||
| Chan et al[ | 1 (not specified) | NA | ||
| Leliveld et al[ | NR | 3 (4%) | NA | |
| Sanders et al[ | 1 (3%) | NR | NA | |
| (Mal)alignment coronal plane mean ± SD° | ||||
| Avilucea et al[ | 3.2 degrees (1.1 degree) | 5.7 degrees (1.8 degrees) | SMD -1.7 degrees | |
| Courtney et al[ | 2.5 degrees (1.9 degrees) | 3.2 degrees (2.0°) | SMD -0.4 degrees [−0.9 to 0.2 degrees] | |
| Fu et al[ | 1.6 degrees (1 degree) | NR | NA | |
| Jones et al[ | 1 degrees (0.8 degrees) | 2 degrees (2.3 degrees) | SMD -0.6 degrees | |
| (Mal)alignment sagittal plane mean ± SD° | ||||
| Avilucea et al[ | 2.9 degrees (1 degree) | 5.5 degrees (2.3 degrees) | SMD -1.5 degrees | |
| Courtney et al[ | 2.9 degrees (2.6 degrees) | 4.6 degrees (2.7 degrees) | SMD 0.6 degrees | |
| Fu et al[ | 2.1 degree (1.3 degrees) | NR | NA | |
| Jones et al[ | 0 degrees (2.2 degrees) | 0° (5.2 degrees) | SMD 0 degrees [−0.5 to 0.5 degrees] | |
| Rotational (mal)alignment cortical width(s) in mm | ||||
| Courtney et al[ | 0.3 (0.4) | 0.3 (0.3) | SMD 0.2 [−0.4 to 0.8] | |
| Non-union cases (%) | ||||
| Chan et al[ | 1 (9%) | 0 (0%) | ||
| Jones et al[ | 1 (1%) | 0 (0%) | ||
| Sanders et al[ | 1 (3%) | NR | NA | |
| Subsequent surgeries cases (%) | ||||
| Cazatto et al[ | 6 (24%) | NR | NA | |
| Chan et al[ | 1 (9%) | 0 (0%) | ||
| Fu et al[ | 11 (48%) | NR | NA | |
| Jones et al[ | 1 (3%) | 0 (0%) | ||
| Leliveld and Verhofstad[ | NR | 44 (62%) | NA | |
| MacDonald et al[ | 13 (25%) | 4 (10%) | ||
| Marecek et al[ | 28 (19%) | 30 (21%) | ||
| Sanders et al[ | 7 (19%) | NR | NA | |
| ROM F/E (flexion/extension) mean arc ± SD | ||||
| Chan et al[ | F/E affected side 131 degrees/0.4 degrees | F/E affected side 137 degrees/0.8 degrees | NA | |
| F/E unaffected side 129 degrees/0.4 degrees | F/E unaffected side 138 degrees/0.8 degrees | |||
| Fu[ | 117.9 degrees (5.31 degrees) | NR | NA | |
| Sanders et al[ | Affected side 124.2 degrees (SD NR) | NR | NA | |
| Unaffected side 127.2 degrees (SD NR) | ||||
Statistically significant.
NR, not reported; NA, not applicable.
Physical Functioning and QoL After the SP Approach Versus the IP Approach
| Study and Outcome | Group(s) | 0–12 mo | >12 mo | |||
| SP | IP | SP | IP | |||
| Physical functioning | ||||||
| IKDC | ||||||
| Cazatto et al[ | SP (25) | NR | NR | 77 (6) | NR | NA |
| OKS | ||||||
| Cazatto et al[ | SP (25) | NR | NR | 42 (6) | NR | NA |
| Courtney et al[ | SP (21) vs. IP (24) | 36 (12) | 40 (9) | NR | NR | SMD -0.4 [−0.9 to 0.2] |
| Kujala score | ||||||
| Cazatto et al[ | SP (25) | NR | NR | 85 (4) | NR | NA |
| Jones et al[ | SP (36) vs. IP (38) | NR | NR | 68 (23) | 75 (19) | SMD 0.3 [−0.8 to 0.1] |
| Leliveld and Verhofstad[ | IP (71) | NR | NR | NR | 83 (16) | NA |
| Ozcan et al[ | SP (21) vs. IP (37) | NR | NR | 80 (9) | 83 (8) | SMD -0.4 [−0.9 to 0.2] |
| Lysholm score | ||||||
| Chan et al[ | SP (11) vs. IP (14) | NR | NR | 98 | 86 | NA |
| Cazatto et al[ | SP (25) | NR | NR | 99 (7) | NR | NA |
| MacDonald et al[ | SP (53) vs. IP (42) | 93 (11) | 84 (20) | NR | NR | SMD 0.6 |
| Ozcan et al[ | SP (21) vs. IP (37) | NR | NR | 85 (8) | 83 (8) | SMD 0.3 [−0.3 to 0.8] |
| Sanders et al[ | SP (36) | NR | NR | Excellent 14; good 8; fair 7; poor 8; | NR | NA |
| HSS | ||||||
| Cui et al[ | SP (24) vs. IP (26) | NR | NR | 97 (5) | 97 (6) | SMD 0 [−0.5 to 0.5] |
| Fu[ | SP (23) | NR | NR | 92 (4) | NR | NA |
| OMAS | ||||||
| Fu et al 2016[ | SP (23) | NR | NR | 94 (4) | NR | NA |
| Irrgang | ||||||
| MacDonald et al[ | SP (53) vs. IP (42) | Total 73 (8); symptoms 32 (4); function 41 (6) | Total 68 (13); symptoms 30 (7); function 38 (7) | NR | NR | SMD 0.5 [0.1 to 0.9] |
| QoL | ||||||
| SF-36 | ||||||
| Cazatto et al[ | SP (25) | NR | NR | 79 (6) | NR | NA |
| Chan et al[ | SP (11) vs. IP (14) | NR | NR | PCS 46 | PCS 38 | NA |
| MCS 47 | MCS 47 | |||||
| Sanders et al[ | SP (36) | NR | NR | PCS 42 | ||
| MCS 48 | NR | NA | ||||
| SF-12 | ||||||
| Jones et al[ | SP (36) vs. IP (38) | NR | NE | PCS 40 (13) | PCS 43 (12) | SMD -0.2 [−0.7 to 0.2] |
| MCS 49 (12) | MCS 51 (9) | SMD 0.2 [−0.3 to 0.6] | ||||
IKDC (scale 0–100, 100 = no pain, no limitations in sports and daily activities), OKS (scale 0–48, 48 = no restrictions in terms of pain and function) Kujala Knee score (scale 0–100, 100 = excellent physical functioning) Lysholm Knee score (scale 0–100, 100 = no disability) HSS (scale 0–100, 100 = no discomfort) OMAS (scale 0–100, 100 = no symptoms and normal physical functioning) Irrgang (scale 0–80, 80 = no symptoms and excellent function) SF-36 (short-form 36), SF-12 (short-form 12), physical component scale (PCS), mental component scale (MCS).
Excellent 95–100, good 84–94, fair 65–83, poor <65.
NR = not reported, NA = not applicable.